Director at Hologic (HOLX) receives 3,190 restricted stock units award

Rhea-AI Filing Summary

Hologic director Ludwig Hantson received an equity award in the form of restricted stock units. On the reported date, he was granted 3,190 RSUs tied to Hologic common stock at no cash cost, classified as a grant or award acquisition. These RSUs are scheduled to vest on the date of the 2027 Annual Meeting of Stockholders and will be settled one-for-one in shares of common stock. After this award, Hantson’s directly held stake is 16,146 shares, which includes 3,695 RSUs whose settlement has been deferred under Hologic’s Deferred Equity Plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HANTSON LUDWIG

(Last) (First) (Middle)

250 CAMPUS DRIVE

(Street)

MARLBOROUGH MA 01752

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HOLOGIC INC [ HOLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		A		3,190(1)	A	(2)	16,146(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units which vest on the date of the 2027 Annual Meeting of Stockholders and are settled in shares of common stock.

2. Restricted stock units are settled in shares of common stock on a one-for-one basis.

3. Includes 3,695 restricted stock units, the settlement of which have been deferred pursuant to the Issuer's Deferred Equity Plan.

	/s/ Mark W. Irving, attorney-in-fact for Dr. Hantson	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Hologic (HOLX) director Ludwig Hantson report in this Form 4?

Ludwig Hantson reported receiving 3,190 restricted stock units in Hologic common stock as a grant. The units were awarded at no cash cost and increase his direct holdings to 16,146 shares, including deferred RSUs under the company’s Deferred Equity Plan.

How many Hologic (HOLX) shares does Ludwig Hantson hold after this grant?

After the grant, Ludwig Hantson directly holds 16,146 shares of Hologic common stock. This total includes 3,695 restricted stock units whose settlement has been deferred under Hologic’s Deferred Equity Plan, in addition to the newly granted 3,190 restricted stock units reported.

What type of Hologic (HOLX) security was granted to Ludwig Hantson?

Ludwig Hantson received restricted stock units linked to Hologic common stock. Each restricted stock unit is designed to be settled on a one-for-one basis in shares of common stock, providing equity-based compensation rather than an immediate cash transaction at the time of the award.

When do Ludwig Hantson’s newly granted Hologic (HOLX) RSUs vest?

The 3,190 restricted stock units awarded to Ludwig Hantson vest on the date of Hologic’s 2027 Annual Meeting of Stockholders. Once vested, they are scheduled to be settled in shares of common stock on a one-for-one basis according to the award terms as disclosed.

Did Ludwig Hantson buy or sell any Hologic (HOLX) shares in this Form 4?

The Form 4 shows an acquisition through a grant of 3,190 restricted stock units, not an open-market buy or sale. The transaction is coded as a grant or award, with no share sale and no purchase price paid per share in this reported transaction.

What is noted about Hologic (HOLX) deferred restricted stock units for Ludwig Hantson?

The filing states that Ludwig Hantson’s holdings include 3,695 restricted stock units whose settlement has been deferred. These units are deferred under Hologic’s Deferred Equity Plan, meaning their conversion into common stock occurs on a later schedule specified by that plan.